Jean-Guy Baril

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

François Raffi, Hans Jaeger, Eugenia Quirós-Roldán et al. · The Lancet Infectious Diseases · 2013 · 372 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database

Madéleine Durand, Odile Sheehy, Jean-Guy Baril et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 281 citations

Public Health, Cardiology, Infectious Diseases +14

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

Darrell H. S. Tan, Mark Hull, Deborah Yoong et al. · Canadian Medical Association Journal · 2017 · 227 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +13

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection

Mohammad-Ali Jenabian, Mohamed El‐Far, Kishanda Vyboh et al. · The Journal of Infectious Diseases · 2015 · 126 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Receptor-Ligand Requirements for Increased NK Cell Polyfunctional Potential in Slow Progressors Infected with HIV-1 Coexpressing KIR3DL1*h/*y and HLA-B*57

Philomena Kamya, Salix Boulet, Christos Tsoukas et al. · Journal of Virology · 2011 · 93 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17